Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hansen, L. A.
Right arrow Articles by Tennant, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, L. A.
Right arrow Articles by Tennant, R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press

research-article

Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice

Laura A. Hansen 1 3, Carol S. Trempus, Joel F. Mahler 2 and Raymond W. Tennant 1 4

1Laboratory of Environmental Carcinogenesis and Mutagenesis Research Triangle Park, NC 27709, USA
2Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences Research Triangle Park, NC 27709, USA

4To whom correspondence should be addressed

The transgenic mouse line TgAC carries a v-Ha-ras gene fused to a fetal ({zeta}) globin promoter and uniquely responds to chemical carcinogens and tumor promotors by the induction of epidermal papillomas. Although the transgene was not constitutively expressed in non-tumor-bearing tissues, expression was induced by exposure to selected chemicals. Tg.AC transgenic mice on the FVB/N background developed occasional spontaneous tumors, including odontomas, squamous cell carcinoma of the salivary gland, leukemias and a rare ovarian yolk sac carcinoma. Both spontaneous and induced tumors are associated with expression of the transgene and, as determined by in situ hybridization, transgene expression is localized to proliferative areas of the tumors. Sequence analysis of the endogenous c-Ha-ras gene in both induced and spontaneous tumors revealed no mutations in codons 12, 59 or 61. These results suggest that expression of the v-Ha-ras transgene induces proliferation of specific cells in diverse tissues which then acquire neoplastic properties.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. J. Jonker, O. Bruning, M. van Iterson, M. M. Schaap, T. V. van der Hoeven, H. Vrieling, R. B. Beems, A. de Vries, H. van Steeg, T. M. Breit, et al.
Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models
Carcinogenesis, October 1, 2009; 30(10): 1805 - 1812.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. P. Waalkes, J. Liu, D. R. Germolec, C. S. Trempus, R. E. Cannon, E. J. Tokar, R. W. Tennant, J. M. Ward, and B. A. Diwan
Arsenic Exposure In utero Exacerbates Skin Cancer Response in Adulthood with Contemporaneous Distortion of Tumor Stem Cell Dynamics
Cancer Res., October 15, 2008; 68(20): 8278 - 8285.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen
Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges
Toxicol Pathol, December 1, 2007; 35(7): 853 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. Fuhrman, L. Shafer, S. Repertinger, T. Chan, and L. A. Hansen
Mechanisms of SEPA 0009-Induced Tumorigenesis in v-rasHa Transgenic Tg.AC Mice
Toxicol Pathol, October 1, 2005; 33(6): 623 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. R. Martin, M. P. Jokinen, H. P. Honeycutt, A. Quinn, F. W. Kari, J. C. Barrett, and J. E. French
Tumor Profile of Novel p53 Heterozygous Tg.AC (v-Ha-ras) Bitransgenic Mice Treated with Benzo(a)pyrene and Fed Dietary N-acetyl-L-cysteine (NAC)
Toxicol. Sci., October 1, 2004; 81(2): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
K. R. Martin, M. P. Jokinen, H. P. Honeycutt, A. Quinn, F. W. Kari, J. C. Barrett, and J. E. French
Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model
Toxicol Pathol, June 1, 2004; 32(4): 418 - 425.
[Abstract] [PDF]

Home page
 International Journal of ToxicologyHome page
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge
Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions
International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice
Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. StJ. Battalora, J. W. Spalding, C. J. Szczesniak, J. E. Cape, R. J. Morris, C. S. Trempus, C. D. Bortner, B. M. Lee, and R. W. Tennant
Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse
Carcinogenesis, April 1, 2001; 22(4): 651 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding
The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model
Toxicol Pathol, January 1, 2001; 29(1_suppl): 51 - 59.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
L. Lan, C. Trempus, and S. K. Gilmour
Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice
Cancer Res., October 1, 2000; 60(20): 5696 - 5703.
[Abstract] [Full Text]

Home page
 Toxicol PatholHome page
W. C. Eastin, J. K. Haseman, J. F. Mahler, and J. R. Bucher
The National Toxicology Program Evaluation of Genetically Altered Mice as Predictive Models for Identifying Carcinogens
Toxicol Pathol, July 1, 1998; 26(4): 461 - 473.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
L. A. Nylander-French and J. E. French
Tripropylene Glycol Diacrylate but Not Ethyl Acrylate Induces Skin Tumors in a Twenty-Week Short-Term Tumorigenesis Study in Tg.AC (v-Ha-ras) Mice
Toxicol Pathol, July 1, 1998; 26(4): 476 - 483.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
J. F. Mahler, N. D. Flagler, D. E. Malarkey, P. C. Mann, J. K. Haseman, and W. Eastin
Spontaneous and Chemically Induced Proliferative Lesions in Tg.AC Transgenic and p53-Heterozygous Mice
Toxicol Pathol, July 1, 1998; 26(4): 501 - 511.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
S. Asano, C. S. Trempus, J. W. Spalding, R. W. Tennant, and M. StJ. Battalora
Morphological Characterization of Spindle Cell Tumors Induced in Transgenic Tg.AC Mouse Skin
Toxicol Pathol, July 1, 1998; 26(4): 512 - 519.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
C. S. Trempus, S. Ward, G. Farris, D. Malarkey, R. S. Faircloth, R. E. Cannon, and J. F. Mahler
Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic Mice
Am. J. Pathol., July 1, 1998; 153(1): 247 - 254.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.